25周年を記念 1999-2024
*3年間で¥ 153396、たったの¥ 61358
フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the Company?) is pleased to announce a jointly signed letter of intent...
CUSIP No. 2332 4Q 20 2 13G Page 1 of 5 Pages UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A...
CUSIP No. 2332 4Q 20 2 13D Page 1 of 5 Pages UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D...
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D. C. 20549 FORM 10-QSB [X] Quarterly report pursuant...
NEW YORK, Sept. 7 /PRNewswire-FirstCall/ -- Richard Gabriel, Chief Executive Officer of DNAPrint Genomics, Inc. (OTC:DNAG) (BULLETIN BOARD:...
DNAPrint genomics Launches New Corporate Marketing and Product Branding Campaign Features Two Redesigned and Upgraded Web Sites SARASOTA, Fla...
DNAPrint genomics' Forensics Technology Featured in Presentation to Florida Sex Crimes Investigators Association SARASOTA, Fla., July 18...
DNAPrint genomics Acquires 18% Stake in German Company Creates New Product Pipeline for Pharmaceutical Products SARASOTA, Fla., July 13...
DNAPrint genomics Upgrades Genotyping Platform SARASOTA, Fla., July 12 /PRNewswire-FirstCall/ -- DNAPrint genomics, Inc. (OTC:DNAG) (BULLETIN...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約